- This event has passed.
Beer & Biotech
January 18 @ 4:30 pm - 6:30 pm
Why are we searching for every single cell?
CytoRecovery, Inc. is bringing to market the Cyto R1, a cell sorting platform for biomedical research. The ability to sort cells from complex biological samples is critical for understanding disease initiation, progression, and treatment. To move toward truly personalized medicine will require precision cell recovery. Our integrated, benchtop platform can enrich and sort cell subpopulations from complex samples. Additionally, the platform operates label-free, so recovery of native samples is feasible for further downstream analysis. With applications spanning oncology, neurology, and single-cell analysis, this new platform will enable life science research across a variety of fields.
About the Speakers
Alex Hyler, Ph.D.: Dr. Alex Hyler is currently the Vice President and Chief Scientific Officer for CytoRecovery, a dynamic startup working to commercialize new cell separation and recovery technologies. Alex has been with the company since its founding in 2018 and currently manages the Company’s operations including product development, R&D, manufacturing, and sales. She earned her Ph.D. in biomedical engineering from the Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences in 2018. During her time at VT, Alex earned a Fulbright to conduct some of her Ph.D. research in Denmark, and she was named the Outstanding Graduate Student of the Year for her work in scholarship and community outreach. Alex is originally from Lawrence, Kansas where she earned her bachelor’s with honors in chemical engineering from the University of Kansas in 2013. When she’s not working, Alex enjoys traveling, watching sports, and spoiling her two dogs.
Steve Turner: Mr. Steve Turner is the Chief Executive Officer for CytoRecovery, a dynamic startup working to commercialize new cell separation and recovery technologies. This endeavor is Steve’s sixth biotechnology company he’s worked with to transition from academia to commercialization. His previous work includes leading two companies that exited and went public, Life Technologies and Oncor. Steve earned his bachelor’s in biology and music performance from Stanford. When he’s not working, Steve enjoys spending time with his family and recording music.